Allstate (NYSE:ALL – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of $3.78 per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.
Allstate (NYSE:ALL – Get Free Report) last posted its quarterly earnings results on Thursday, February 8th. The insurance provider reported $5.82 earnings per share for the quarter, topping the consensus estimate of $3.87 by $1.95. The business had revenue of $14.83 billion during the quarter, compared to the consensus estimate of $12.69 billion. Allstate had a negative net margin of 0.33% and a positive return on equity of 2.67%. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm posted ($1.36) earnings per share. On average, analysts expect Allstate to post $13 EPS for the current fiscal year and $17 EPS for the next fiscal year.
Allstate Trading Down 0.1 %
Shares of ALL opened at $175.27 on Wednesday. The stock has a market capitalization of $46.11 billion, a P/E ratio of -141.35, a PEG ratio of 0.42 and a beta of 0.52. The firm has a fifty day simple moving average of $164.50 and a two-hundred day simple moving average of $148.42. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.51. Allstate has a twelve month low of $100.57 and a twelve month high of $176.93.
Allstate Increases Dividend
Wall Street Analyst Weigh In
ALL has been the subject of a number of recent analyst reports. Piper Sandler upped their price target on shares of Allstate from $172.00 to $188.00 and gave the stock an “overweight” rating in a research report on Monday, April 1st. UBS Group boosted their target price on shares of Allstate from $171.00 to $185.00 and gave the stock a “buy” rating in a report on Monday, February 12th. The Goldman Sachs Group boosted their price objective on Allstate from $164.00 to $195.00 and gave the stock a “buy” rating in a research note on Monday, March 25th. JPMorgan Chase & Co. increased their target price on shares of Allstate from $172.00 to $185.00 and gave the company an “overweight” rating in a research note on Monday, April 8th. Finally, Morgan Stanley lifted their price target on shares of Allstate from $187.00 to $190.00 and gave the company an “overweight” rating in a research note on Monday, April 15th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Allstate currently has an average rating of “Moderate Buy” and an average target price of $173.71.
Read Our Latest Stock Analysis on ALL
Insider Activity
In related news, insider John E. Dugenske sold 31,000 shares of the stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the sale, the insider now owns 63,731 shares of the company’s stock, valued at $10,847,016.20. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Allstate news, CAO John C. Pintozzi sold 4,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total value of $637,880.00. Following the transaction, the chief accounting officer now directly owns 10,736 shares of the company’s stock, valued at approximately $1,712,069.92. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider John E. Dugenske sold 31,000 shares of Allstate stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total value of $5,276,200.00. Following the completion of the transaction, the insider now owns 63,731 shares of the company’s stock, valued at $10,847,016.20. The disclosure for this sale can be found here. Insiders own 1.80% of the company’s stock.
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- The 3 Best Fintech Stocks to Buy Now
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Why Invest in High-Yield Dividend Stocks?
- Lockheed Martin Stock Aims for a Fresh All-Time High
- How to Use the MarketBeat Stock Screener
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.